Tuberculosis News and Research

Latest Tuberculosis News and Research

New genetic markers could improve early detection of drug-resistant tuberculosis

To many, tuberculosis (TB) may seem like a disease from a bygone era. But it still claims more than one million lives every year.

9 May 2022

Researchers investigate IgG antibodies against Mtb proteins in an Asian elephant cured of tuberculosis

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb); the leading cause of human death due to a single pathogen before the emergence of SARS-CoV-2.

9 May 2022

Evaluation of the potential of new and repurposed TB vaccines

A new study evaluated effective vaccination strategies for two TB vaccines, M72/AS01E and BCG.

5 May 2022

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill them.

4 May 2022

Researchers reveal the mechanism of action of century-old BCG vaccine

The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, it has surprisingly been found to protect newborns and young infants against multiple bacterial and viral infections unrelated to TB. There's even some evidence that it can reduce severity of COVID-19.

4 May 2022

New insight into the body’s response to tuberculosis may help design a more effective vaccine

More than 1.7 billion people-; or a quarter of the world's population-; are infected with Mycobacterium tuberculosis, the bacterial strain that causes tuberculosis (TB).

27 Apr 2022

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

As part of World Immunization Week 2022, News Medical speaks to the International Vaccine Institute about their fight against vaccine inequity, as well as what a “Long Life for All” means to them.

25 Apr 2022

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

In a recent study posted to the bioRxiv* preprint server, the researchers investigated the impact of Bacillus Calmette-Guérin (BCG) vaccine-induced antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein.

25 Apr 2022

Moisture in the air crucial for the survival and spread of tuberculosis

Climatic factors such as dew point temperature, relative humidity and atmospheric temperature that affect water droplet formation are crucial for the survival and spread of tuberculosis (TB), an airborne infectious disease, say researchers.

21 Apr 2022

Revolutionary mRNA vaccine technology: History, facts and the future

mRNA vaccine technology is a field full of promise – as well as unanswered questions – for communities living with the burden of the world’s most deadly infectious diseases.

20 Apr 2022

Two strains of TB bacterium attack the lungs in completely different fashion, study finds

Two strains of the bacterium causing tuberculosis have only minor genetic differences but attack the lungs in completely different fashion, according to Rutgers researchers.

18 Apr 2022

Monitoring medication adherence for TB treatment in Africa using AI

Researchers aimed to develop an AI system that can evaluate medication adherence and non-adherence activities of TB patients based on their visual attributes obtained from videos.

11 Apr 2022

Researchers demonstrate how a narrow-spectrum antibiotic selectively targets C. diff

Most antibiotics are double-edged swords. Besides killing the pathogen they are prescribed for, they also decimate beneficial bacteria and change the composition of the gut microbiome.

6 Apr 2022

COVID-19 pandemic had substantial effect on TB trends in the United States

In the United States, reported tuberculosis (TB) disease diagnoses fell 20% in 2020 and remained 13% lower in 2021 than TB disease diagnoses made prior to the COVID-19 pandemic, according to preliminary CDC data published today.

29 Mar 2022

Tuberculosis infection protects mice against COVID-19

To study if prior Mtb infection affects the response to CoV2 infection, K18-hACE2 (ACE2) and C57BL/6 (B6) mice were infected with Mtb, and post thirty days, were exposed to CoV2.

27 Mar 2022

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Most of the world's countries have made little progress towards a target adopted by the United Nations in 2015, which called for the world to reduce premature mortality from non-communicable diseases by a third by 2030.

27 Mar 2022

Extensive immediate actions needed for global control of tuberculosis

Announcing a new article publication for Zoonoses journal. In this article the authors discuss how extensive immediate actions worldwide are required to progress toward a tuberculosis-free world.

24 Mar 2022

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis.

24 Mar 2022

Short duration treatment effective in combating most childhood TB cases, study says

Short duration treatment — four months instead of the standard six — is as effective in combating most cases of childhood tuberculosis (TB), says a study carried out in India and some African countries.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

For World Tuberculosis Day 2022, News Medical spoke to Dr. Michael Lauzardo, director of the Southeastern National TB Center, to raise awareness of this infectious disease.

24 Mar 2022

Tuberculosis News and Research

Latest Tuberculosis News and Research

New genetic markers could improve early detection of drug-resistant tuberculosis

Researchers investigate IgG antibodies against Mtb proteins in an Asian elephant cured of tuberculosis

Evaluation of the potential of new and repurposed TB vaccines

Study identifies a protein in Mycobacterium tuberculosis that contributes to drug tolerance

Researchers reveal the mechanism of action of century-old BCG vaccine

New insight into the body’s response to tuberculosis may help design a more effective vaccine

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Study suggests BCG vaccination might confer immunity to SARS-CoV-2

Moisture in the air crucial for the survival and spread of tuberculosis

Revolutionary mRNA vaccine technology: History, facts and the future

Two strains of TB bacterium attack the lungs in completely different fashion, study finds

Monitoring medication adherence for TB treatment in Africa using AI

Researchers demonstrate how a narrow-spectrum antibiotic selectively targets C. diff

COVID-19 pandemic had substantial effect on TB trends in the United States

Tuberculosis infection protects mice against COVID-19

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Extensive immediate actions needed for global control of tuberculosis

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Short duration treatment effective in combating most childhood TB cases, study says

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Tuberculosis News and Research

Latest Tuberculosis News and Research

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Newsletters you may be interested in